Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts
September 22 2020 - 10:00AM
Business Wire
Pfizer Inc. (NYSE: PFE) invites investors and the general public
to view and listen to a webcast of a conference call with
investment analysts at 10 a.m. EDT on Tuesday, October 27, 2020.
The purpose of the call is to provide an update on Pfizer’s
results, as reflected in the company’s Third Quarter 2020
Performance Report, to be issued that morning.
To view and listen to the webcast and view the Performance
Report, visit our web site at www.pfizer.com/investors. Information
on accessing and pre-registering for the webcast will be available
at www.pfizer.com/investors beginning today. Participants are
advised to register in advance of the conference call.
You can also listen to the conference call by dialing either
(877) 825-3082 in the United States and Canada or (503) 343-6044
outside of the United States and Canada. The password is “Third
Quarter Earnings”.
Visitors to www.pfizer.com/investors will be able to view and
listen to an archived copy of the webcast of the conference
call.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 150 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our
anticipated operating and financial performance, business plans and
prospects, expectations for our product pipeline, in-line products
and product candidates, including anticipated regulatory
submissions, data read-outs, study starts, approvals, revenue
contribution, growth, performance, timing of exclusivity and
potential benefits, manufacturing and product supply, our efforts
to respond to COVID-19, including our investigational vaccine
candidate against SARS-CoV-2 and our investigational protease
inhibitor, our expectations regarding the impact of COVID-19, our
ability to successfully capitalize on growth opportunities and
prospects; plans for and prospects of our acquisitions and other
business development activities, including our proposed transaction
with Mylan N.V. (Mylan) to combine Upjohn and Mylan to create a new
global pharmaceutical company and plans relating to share
repurchases and dividends, among other things, that are subject to
substantial risks and uncertainties that could cause actual results
to differ materially from those expressed or implied by such
statements. A description of these risks and uncertainties can be
found in Pfizer’s Annual Report on Form 10-K for the fiscal year
ended December 31, 2019 and in its subsequent reports on Form 10-Q,
including in the sections thereof captioned “Risk Factors” and
“Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of
which are filed with the U.S. Securities and Exchange Commission
and available at www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200922005013/en/
Media Relations:
Amy Rose +1 (646) 592-3157 Amy.Rose@Pfizer.com Investor
Relations: Bryan Dunn
+1 (212) 733-8917
Bryan.Dunn@Pfizer.com
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2023 to Sep 2024